Avatrombopag: First Global Approval

Shirley, M

Shirley, M (reprint author), Springer, Private Bag 65901, Auckland 0754, New Zealand.

DRUGS, 2018; 78 (11): 1163

Abstract

Avatrombopag (Doptelet(A (R))) is an orally bioavailable, small molecule thrombopoietin receptor agonist that has been developed by Dova Pharmaceutica......

Full Text Link